Q3 2026 13F filing
Updated 6 days ago47 disclosed positions worth $3B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | R REVOLUTION MEDICINES INC | $505.1M | 2.46M | 16.61% | — |
| 2 | K KYMERA THERAPEUTICS INC | $432.9M | 3.87M | 14.24% | — |
| 3 | G GH RESEARCH PLC | $203.1M | 8.65M | 6.68% | — |
| 4 | M MOONLAKE IMMUNOTHERAPEUTICS | $187.2M | 16.00M | 6.16% | — |
| 5 | X XENCOR INC | $155.4M | 6.23M | 5.11% | — |
| 6 | N NEKTAR THERAPEUTICS | $129.2M | 2.13M | 4.25% | — |
| 7 | A ALKERMES PLC | $115.4M | 2.85M | 3.79% | — |
| 8 | S STOKE THERAPEUTICS INC | $93.8M | 3.61M | 3.09% | — |
| 9 | T TYRA BIOSCIENCES INC | $92.2M | 4.22M | 3.03% | — |
| 10 | Z ZYMEWORKS INC | $91.8M | 3.46M | 3.02% | — |
| 11 | C CULLINAN THERAPEUTICS INC | $88.3M | 5.75M | 2.90% | — |
| 12 | G STRUCTURE THERAPEUTICS INC | $84.2M | 2.69M | 2.77% | — |
| 13 | P PALVELLA THERAPEUTICS INC NE | $83.7M | 607.1K | 2.75% | — |
| 14 | K KURA ONCOLOGY INC | $71.7M | 6.69M | 2.36% | — |
| 15 | A AC IMMUNE SA | $51.9M | 19.82M | 1.71% | — |
| 16 | M MONTE ROSA THERAPEUTICS INC | $51M | 4.28M | 1.68% | — |
| 17 | E ENTERA BIO LTD | $49.6M | 17.05M | 1.63% | — |
| 18 | O OLEMA PHARMACEUTICALS INC | $45.8M | 5.30M | 1.51% | — |
| 19 | C CRESCENT BIOPHARMA INC. | $45.1M | 3.09M | 1.48% | — |
| 20 | F 4D MOLECULAR THERAPEUTICS IN | $41.2M | 2.88M | 1.36% | — |
| 21 | I IMMUNOCORE HLDGS PLC | $37.3M | 1.23M | 1.23% | — |
| 22 | A ANNEXON INC | $35M | 8.28M | 1.15% | — |
| 23 | M MIRUM PHARMACEUTICALS INC | $34.8M | 407.2K | 1.15% | — |
| 24 | S SAGIMET BIOSCIENCES INC | $34.6M | 3.50M | 1.14% | — |
| 25 | Q PYXIS ONCOLOGY INC | $27.6M | 11.83M | 0.91% | — |
| 26 | A ABSCI CORPORATION | $25.4M | 2.36M | 0.84% | — |
| 27 | I INVIVYD INC | $24.5M | 28.16M | 0.81% | — |
| 28 | A ANTERIS TECHNOLOGIES GLOBAL | $23.3M | 3.00M | 0.77% | — |
| 29 | F FOGHORN THERAPEUTICS INC | $20.9M | 5.84M | 0.69% | — |
| 30 | ? N/A SUTRO BIOPHARMA INC | $20.2M | 1.25M | 0.66% | — |
| 31 | Q Q32 BIO INC | $19.4M | 2.35M | 0.64% | — |
| 32 | A ALECTOR INC | $18.6M | 10.05M | 0.61% | — |
| 33 | E ELEDON PHARMACEUTICALS INC | $15.9M | 6.29M | 0.52% | — |
| 34 | I DISC MEDICINE INC | $15.3M | 233.3K | 0.50% | — |
| 35 | A AVALO THERAPEUTICS INC | $13.9M | 907.4K | 0.46% | — |
| 36 | O ONKURE THERAPEUTICS INC | $11M | 4.05M | 0.36% | — |
| 37 | I IMMUNIC INC | $7.1M | 765.3K | 0.23% | — |
| 38 | ? N/A TCGX ACQUISITION CORP | $6.3M | 500.0K | 0.21% | — |
| 39 | R RESEARCH ALLIANCE CORP IV | $5.9M | 500.0K | 0.19% | — |
| 40 | R RESEARCH ALLIANCE CORP III | $5.4M | 500.0K | 0.18% | — |
| 41 | M MOLECULAR PARTNERS AG | $5.2M | 1.35M | 0.17% | — |
| 42 | I IMAGENEBIO INC | $5.1M | 1.11M | 0.17% | — |
| 43 | ? N/A X4 PHARMACEUTICALS INC | $4.6M | 1.58M | 0.15% | — |
| 44 | I INVENTIVA SA | $2.5M | 686.0K | 0.08% | — |
| 45 | T TSCAN THERAPEUTICS INC | $1.7M | 5.56M | 0.06% | — |
| 46 | E ENGENE THERAPEUTICS INC | $189K | 945.4K | 0.01% | — |
| 47 | T TENAX THERAPEUTICS INC | $47K | 25.0K | 0.00% | — |